Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Lang · SciRah

Researcher profile · Semantic Scholar

A. Lang

Share profile

A. Lang — researcher profile on SciRah

h-index: 2
Works: 23
Citations: 194

Most-cited papers

Acute myeloid leukemia management and research in 2025
H. Kantarjian, C. Dinardo, T. Kadia, Naval G. Daver +6 more
2024Ca180 citations
Semantic Scholar
Relationship between CYP2D6 and estrogen receptor alpha polymorphisms on tamoxifen metabolism in adjuvant breast cancer treatment.
J. Grabinski, L. Smith, Gary B. Chisholm, R. Drengler +7 more
2006Journal of Clinical Oncology10 citations
Semantic Scholar
Phase I development of a weekly dosing schedule for the oral taxane tesetaxel.
A. Lang, M. Beeram, A. Tolcher, K. Papadopoulos +6 more
20122 citations
Semantic Scholar
Abstract 3869: Short or long-term treatment with CDK4/6 inhibitors in patients with ER+ breast cancer: characterization and comparative analysis of resistance in seventeen XPDX models
A. Simonson, J. Flores, Morgan Lynch, E. Carpenter +13 more
2023Cancer Research1 citations
Semantic Scholar
Abstract P1-13-03: Establishment and characterization of two T-DM1-resistant, ER+/HER2+ breast XPDX models developed sequentially from the same patient with differential in vivo sensitivity to trastuzumab deruxtecan (DS-8201a)
George Plasko, J. Flores, A. Simonson, P. Forofontov +9 more
2023Cancer Research1 citations
Semantic Scholar
Abstract 3855: Establishment and characterization of a panel of breast XPDX models representing innate or acquired resistance to trastuzumab deruxtecan (T-DXd)
Maci DeBoer, A. Paez, J. Flores, Robyn Baeza +12 more
2023Cancer Research1 citations
Semantic Scholar
96 Evaluation of hormone therapies in a panel of breast PDX models: Relevance of ER status on sensitivity to letrozole and tamoxifen
M. Wick, T. Vaught, L. Gamez, J. Meade +7 more
20141 citations
Semantic Scholar
Abstract P3-02-20: CDK4/6 inhibitor resistance in patients with ER+ breast cancer: Identification and characterization of resistance mechanisms in thirty-two XPDX models
Delaney Rushing, A. Simonson, J. Flores, A. Stackpole +17 more
2025Clinical Cancer Research0 citations
Semantic Scholar
Abstract PO1-26-03: Activity of alpelisib in a panel of breast XPDX models harboring hotspot and uncommon PIK3CA mutations
M. Castañeda, A. Simonson, J. Flores, Maci DeBoer +16 more
2024Cancer Research0 citations
Semantic Scholar
Abstract PO1-26-02: Enfortumab vedotin (EV): Correlation of estrogen receptor status and Nectin-4 expression with single agent efficacy in breast XPDX models
C. Moreno, J. Flores, A. Simonson, Maci DeBoer +21 more
2024Cancer Research0 citations
Semantic Scholar
Abstract P3-08-05: Correlation of Trop2 expression with in vivo sensitivity to sacituzumab govitecan in a panel of breast XPDX models
A. Simonson, J. Flores, E. Anderson, C. Moreno +19 more
2023Cancer Research0 citations
Semantic Scholar
Identification and molecular characterization of invasive lobular breast cancer models in a panel of 180 breast XPDX models
J. Flores, A. Moriarty, F. Lizette, A. Lang +16 more
2022European Journal of Cancer0 citations Open access
Semantic Scholar
Abstract 1092: Correlation of platinum sensitivity with donor patient treatment status in a panel of breast, ovary, uterine, and lung XPDX models
A. Simonson, J. Flores, Lizette Firova, C. Hernández +10 more
2022Cancer Research0 citations
Semantic Scholar
Abstract P5-01-04: Correlation of HER2 receptor expression and in vivo activity of the HER2-targeting therapies trastuzumab deruxtecan (DS-8201a) and T-DM1 activity in a panel of breast XPDX models
A. Simonson, P. Forofontov, J. Flores, Kimberly Hernandez +15 more
2022Cancer Research0 citations
Semantic Scholar
Abstract P5-01-06: Establishment and characterization of luminal A breast XPDX models from patients with acquired resistance to CDK 4/6 inhibitors
T. Hernandez, D. Kneifel, A. Simonson, J. Flores +11 more
2022Cancer Research0 citations
Semantic Scholar
Abstract P5-01-09: Establishment and characterization of two simultaneously developed T-DM1-resistant, ER+/HER2+ XPDX models from the same patient with differential in vivo sensitivity to trastuzumab deruxtecan (DS-8201a)
J. Flores, A. Stackpole, Abimael Garza, Alexandra Ulmer +10 more
2022Cancer Research0 citations
Semantic Scholar
Abstract P5-01-11: Nonclinical activity of fulvestrant in a panel of ER+ breast XPDX models representing clinically acquired and innate resistance to endocrine therapies
April B. Cabang, C. Moreno, J. Flores, Jenna Boedeker +15 more
2022Cancer Research0 citations
Semantic Scholar
Abstract A008: PDX-based screen to evaluate and compare approved CDK4/6 inhibitors in breast cancer and determine palbociclib efficacy in additional tumor types
L. Gamez, T. Mashimo, A. Moriarty, K. Papadopoulos +6 more
2019Animal Models0 citations
Semantic Scholar
Abstract A017: Development and characterization of HER2+ T-DM1-resistant breast PDX models in athymic nude mice
A. Moriarty, L. Gamez, T. Mashimo, K. Papadopoulos +5 more
2019Animal Models0 citations
Semantic Scholar
Abstract P3-03-04: Establishment and characterization of ESR1-mutant breast cancer PDX models
M. Wick, E. Helman, J. Meade, M. Clark +7 more
20160 citations
Semantic Scholar
Abstract C104: Preclinical sensitivity of low and high-HER2 expressing START-PDX breast models to T-DM1 and effects of HER3 expression on drug antitumor activity.
M. Wick, Jennifer R. Brown, T. Vaught, J. Meade +6 more
20130 citations
Semantic Scholar
56 Establishment, Characterization and Evaluation of a Panel of Patient-derived Low Passage Breast Tumor Models
M. Wick, T. Vaught, S. Kelly, M. Farley +6 more
20120 citations
Semantic Scholar
Tesetaxel: Development of a weekly dosing schedule for an oral advanced-generation taxane.
M. Beeram, A. Tolcher, K. Papadopoulos, A. Lang +4 more
2011Journal of Clinical Oncology0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

K. Papadopoulos×19
Invite
K. Papadopoulos — researcher profile on SciRah
A. Patnaik×17
Invite
A. Patnaik — researcher profile on SciRah
M. Beeram×16
Invite
M. Beeram — researcher profile on SciRah
J. Flores×13
Invite
J. Flores — researcher profile on SciRah

×13

Invite

M. Wick — researcher profile on SciRah

A. Simonson×12

Invite

A. Simonson — researcher profile on SciRah

R. Drengler×11

Invite

R. Drengler — researcher profile on SciRah

Invite

D. Rasco — researcher profile on SciRah

Invite

L. Smith — researcher profile on SciRah

G. Rodriguez×7

Invite

G. Rodriguez — researcher profile on SciRah

Invite

A. Tolcher — researcher profile on SciRah

A. Rosenthal×6

Invite

A. Rosenthal — researcher profile on SciRah